Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas

Archives of Dermatological Research

Volumn 297, Issue 9, 2006, Pages 421-424

  Sirén, Vappu ^a   Peltonen, Juha ^b   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Immunohistochemistry; In situ hybridization; PAI 1; tPA; Type 1 neurofibromatosis; uPA

Indexed keywords

ANTIGEN; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MAST CELL; NEURINOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN TUMOR; TUMOR CELL;

ADULT; ENDOTHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MAST CELLS; MIDDLE AGED; NEUROFIBROMATOSIS 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; RNA, MESSENGER; SKIN NEOPLASMS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33344455801     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-005-0637-x     Document Type: Article

References (14)

1. Clark MB, Zeheb R, White TK, Bunge RP (1991) Schwann cell plasminogen activator is regulated by neurons. Glia 4:514-528
2. Collen D (1979) On the regulation of fibrinolysis. Thromb Haemost 43:77-89
3. Declerck PJ, De Mal M, Alessi M-C, Baudner S, Paques EP, Preissner KT, Muller-Berghaus G, Collen D (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454-15461
4. Evans GR, Scheithauer B, Komminoth P, Peltonen J (2004) Neurofibromatosis 1. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and Genetics: tumours of endocrine organs, Chap 5. Inherited tumour syndromes. IARCPress, Lyon, pp 243-248
5. Ferrier CM, Suciu S, van Geloof WL, Straatman H, Eggermont AM, Koops HS, Kroon BB, Lejeune FJ, Kleeberg UR, van Muijen GN, Ruiter DJ (2000) High tPA-expression in primary melanoma of the limb correlates with good prognosis. Br J Cancer 83:1351-1359
6. Myöhänen H, Vaheri A (2004) Regulation and interactions in the activation of cell-associated plasminogen. Cell Mol Life Sci 61:1-19
7. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760-771
8. Register B, Delree P, Leprince P, Martin D, Sadzot C, Malgrange B, Munaut C, Rigo JM, Lefebyre PP, Octave JN (1993) Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 34:32-43
9. Salonen E-M, Vaheri A, Pöllänen J, Stephens RW, Andreasen PA, Mayer M, Danø K, Gailit J, Ruoslahti E (1989) Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264:6339-6343
10. Sawaya R, Rämö J, Shi ML, Mandybur G (1991) Biological significant of tissue plasminogen activator content in brain tumors. J Neurosurg 74:480-486
11. Sillaber C, Baghestanian M, Bevec D, Willheim M, Agis H, Kapiotis S, Fureder W, Bankl HC, Kiener HP, Speiser W, Binder BR, Lechner K, Valent P (1999) The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol 162(2):1032-1041
12. Sirén V, Antinheimo J-P, Jääskeläinen J, Böhling T, Carpén O, Vaheri A (2004) Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas. Acta Neurochir 146:111-118
13. Teesalu T, Kulla A, Simisker A, Sirén V, Lawrence DA, Vaheri A (2004) Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 92:358-368
14. Yamashita J, Ogawa M, Yamashita S, Nakashima T, Saishoji T, Nomura K, Inada K, Kawana I (1993) Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer. Br J Cancer 68:524-529